Site-specific Mutations in HIV-1 gp41 Reveal a Correlation between HIV-1-mediated Bystander Apoptosis and Fusion/Hemifusion (Q57372687)

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Mechanisms of apoptosis induction by the HIV-1 envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Envelope glycoprotein determinants of increased fusogenicity in a pathogenic simian-human immunodeficiency virus (SHIV-KB9) passaged in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

HIV gp41-induced apoptosis is mediated by caspase-3-dependent mitochondrial depolarization, which is inhibited by HIV protease inhibitor nelfinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Role of the ectodomain of the gp41 transmembrane envelope protein of human immunodeficiency virus type 1 in late steps of the membrane fusion process

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Membrane hemifusion: crossing a chasm in two leaps

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced by cell membrane-associated human immunodeficiency virus type 1 envelope glycoprotein (gp120).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Binding of human immunodeficiency virus type 1 gp120 to CXCR4 induces mitochondrial transmembrane depolarization and cytochrome c-mediated apoptosis independently of Fas signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Fusion-induced apoptosis contributes to thymocyte depletion by a pathogenic human immunodeficiency virus type 1 envelope in the human thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Mitochondrial apoptosis induced by the HIV-1 envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Inhibition of adenine nucleotide translocator pore function and protection against apoptosis in vivo by an HIV protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Inefficient human immunodeficiency virus replication in mobile lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

The HIV Env-mediated fusion reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Enfuvirtide resistance mutations: impact on human immunodeficiency virus envelope function, entry inhibitor sensitivity, and virus neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

The inhibition of pro-apoptotic ICE-like proteases enhances HIV replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Protein-Lipid Interplay in Fusion and Fission of Biological Membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Caspase-3 is a component of Fas death-inducing signaling complex in lipid rafts and its activity is required for complete caspase-8 activation during Fas-mediated cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Human immunodeficiency virus type 1 virological synapse formation in T cells requires lipid raft integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200

Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701701200